Lifecore Biomedical Intergel
This article was originally published in The Gray Sheet
Executive Summary
Sales of the hyaluronic acid-based anti-adhesion solution to Johnson & Johnson/Ethicon's Gynecare division were $4.3 mil. for the 12 months ended June 30, comprising 11% of Lifecore's $38.8 mil. annual revenue, the company reports. Gynecare Intergel debuted in the U.S. at the end of the third quarter. The introduction helped boost Lifecore Hyaluronan Division revenues 37% in the fourth quarter to nearly $5 mil...